Clinical staging on CT has several biases, and a radiogenomics approach could be proposed. The study aimed to test the performance of a radiogenomics approach in identifying high-risk colon cancer. ATTRACT is a multicentric trial, registered in ClinicalTrials.gov (NCT06108310). Three hundred non-metastatic colon cancer patients were retrospectively enrolled and divided into two groups, high-risk and no-risk, according to the pathological staging. Radiological evaluations were performed by two abdominal radiologists. For 151 patients, we achieved genomics. The baseline CT scans were used to evaluate the radiological assessment and to perform 3D cancer segmentation. One expert radiologist used open-source software to perform the volumetric cancer segmentations on baseline CT scans in the portal phase (3DSlicer v4.10.2). Implementing the classical LASSO with a machine-learning library method was used to select the optimal features to build Model 1 (clinical-radiological plus radiomic feature, 300 patients) and Model 2 (Model 1 plus genomics, 151 patients). The performance of clinical-radiological interpretation was assessed regarding the area under the curve (AUC), sensitivity, specificity, and accuracy. The average performance of Models 1 and 2 was also calculated. In total, 262/300 were classified as high-risk and 38/300 as no-risk. Clinical-radiological interpretation by the two radiologists achieved an AUC of 0.58-0.82 (95% CI: 0.52-0.63 and 0.76-0.85, p < 0.001, respectively), sensitivity: 67.9-93.8%, specificity: 47.4-68.4%, and accuracy: 65.3-90.7%, respectively. Model 1 yielded AUC: 0.74 (95% CI: 0.61-0.88, p < 0.005), sensitivity: 86%, specificity: 48%, and accuracy: 81%. Model2 reached AUC: 0.84, (95% CI: 0.68-0.99, p < 0.005), sensitivity: 88%, specificity: 63%, and accuracy: 84%. The radiogenomics model outperformed radiological interpretation in identifying high-risk colon cancer. Question Can this radiogenomic model identify high-risk stages II and III colon cancer in a preoperative clinical setting? Findings This radiogenomics model outperformed both the radiomics and radiological interpretations, reducing the risk of improper staging and incorrect treatment options. Clinical relevance The radiogenomics model was demonstrated to be superior to radiological interpretation and radiomics in identifying high-risk colon cancer, and could therefore be promising in stratifying high-risk and low-risk patients.

Computed tomography (CT) analysis of lung morphology has significantly advanced our understanding of acute respiratory distress syndrome (ARDS). During the Coronavirus Disease 2019 (COVID-19) pandemic, CT imaging was widely utilized to evaluate lung injury and was suggested as a tool for predicting patient outcomes. However, data specifically focused on patients with ARDS admitted to intensive care units (ICUs) remain limited. This retrospective study analyzed patients admitted to ICUs between March 2020 and November 2022 with moderate to severe COVID-19 ARDS. All CT scans performed within 48 h of ICU admission were independently reviewed by three experts. Lung injury severity was quantified using the CT Severity Score (CT-SS; range 0-25). Patients were categorized as having severe disease (CT-SS ≥ 18) or non-severe disease (CT-SS < 18). The primary outcome was all-cause mortality at 90 days. Secondary outcomes included ICU mortality and medical complications during the ICU stay. Additionally, we evaluated a computer-assisted CT-score assessment using artificial intelligence software (CT Pneumonia Analysis^®, SIEMENS Healthcare) to explore the feasibility of automated measurement and routine implementation. A total of 215 patients with moderate to severe COVID-19 ARDS were included. The median CT-SS at admission was 18/25 [interquartile range, 15-21]. Among them, 120 patients (56%) had a severe CT-SS (≥ 18), while 95 patients (44%) had a non-severe CT-SS (< 18). The 90-day mortality rates were 20.8% for the severe group and 15.8% for the non-severe group (p = 0.35). No significant association was observed between CT-SS severity and patient outcomes. In patients with moderate to severe COVID-19 ARDS, systematic CT assessment of lung parenchymal injury was not a reliable predictor of 90-day mortality or ICU-related complications.

The two-dimensional computed tomography measurement of the consolidation tumor ratio (2D-CTR) has limitations in the prognostic evaluation of early-stage lung adenocarcinoma: the measurement is subject to inter-observer variability and lacks spatial information, which undermines its reliability as a prognostic tool. This study aims to investigate the value of the three-dimensional volume-based CTR (3D-CTR) in preoperative prognosis prediction for pathological Stage IA lung adenocarcinoma, and compare its predictive performance with that of 2D-CTR. A retrospective cohort of 980 patients with pathological Stage IA lung adenocarcinoma who underwent surgery was included. Preoperative thin-section CT images were processed using artificial intelligence (AI) software for 3D segmentation. Tumor solid component volume was quantified using different density thresholds (-300 to -150 HU, in 50 HU intervals), and 3D-CTR was calculated. The optimal threshold associated with prognosis was selected using multivariate Cox regression. The predictive performance of 3D-CTR and 2D-CTR for recurrence-free survival (RFS) post-surgery was compared using receiver operating characteristic (ROC) curves, and the best cutoff value was determined. The integrated discrimination improvement (IDI) was utilized to assess the enhancement in predictive efficacy of 3D-CTR relative to 2D-CTR. Among traditional preoperative factors, 2D-CTR (cutoff value 0.54, HR=1.044, P=0.001) and carcinoembryonic antigen (CEA) were identified as independent prognostic factors for RFS. In 3D analysis, -150 HU was determined as the optimal threshold for distinguishing solid components from ground-glass opacity (GGO) components. The corresponding 3D-CTR (cutoff value 0.41, HR=1.033, P<0.001) was an independent risk factor for RFS. The predictive performance of 3D-CTR was significantly superior to that of 2D-CTR (AUC: 0.867 vs. 0.840, P=0.006), with a substantial enhancement in predictive capacity, as evidenced by an IDI of 0.038 (95% CI: 0.021-0.055, P<0.001). Kaplan-Meier analysis revealed that the 5-year RFS rate for the 3D-CTR >0.41 group was significantly lower than that of the ≤0.41 group (68.5% vs. 96.7%, P<0.001). The 3D-CTR based on a -150 HU density threshold provides a more accurate prediction of postoperative recurrence risk in pathological Stage IA lung adenocarcinoma, demonstrating superior performance compared to traditional 2D-CTR.

Computed tomography is an inadequate method for detecting myocardial focal scar (MFS) due to its moderate density resolution, which is insufficient for distinguishing MFS from artificial beam-hardening (BH). Virtual monochromatic images (VMIs) of dual-energy coronary computed tomography angiography (DECCTA) provide a variety of diagnostic information with significant potential for detecting myocardial lesions. The aim of this study was to assess whether radiomics analysis in VMIs of DECCTA can help distinguish MFS from BH. A prospective cohort of patients who were suspected with an old myocardial infarction was assembled at two different centers between Janurary 2021 and June 2024. MFS and BH segmentation and radiomics feature extraction and selection were performed on VMIs images, and four machine learning classifiers were constructed using selected strongest features. Subsequently, an independent validation was conducted, and a subjective diagnosis of the validation set was provided by an radiologist. The AUC was used to assess the performance of the radiomics models. The training set included 57 patients from center 1 (mean age, 54 years +/- 9, 55 men), and the external validation set included 10 patients from center 2 (mean age, 59 years +/- 10, 9 men). The radiomics models exhibited the highest AUC value of 0.937 (expressed at 130 keV VMIs), while the radiologist demonstrated the highest AUC value of 0.734 (expressed at 40 keV VMIs). The integration of radiomic features derived from VMIs of DECCTA with machine learning algorithms has the potential to improve the efficiency of distinguishing MFS from BH.

Lung cancer is one of the main threats to global health, among lung diseases. Low-Dose Computed Tomography (LDCT) provides significant benefits for its screening but also brings new diagnostic challenges that require close attention. By searching the Web of Science core collection, we selected articles and reviews published in English between 2005 and June 2024 on topics such as "Low-dose", "CT image", and "Lung". These literatures were analyzed by bibliometric method, and CiteSpace software was used to explore the cooperation between countries, the cooperative relationship between authors, highly cited literature, and the distribution of keywords to reveal the research hotspots and trends in this field. The number of LDCT research articles show a trend of continuous growth between 2019 and 2022. The United States is at the forefront of research in this field, with a centrality of 0.31; China has also rapidly conducted research with a centrality of 0.26. The authors' co-occurrence map shows that research teams in this field are highly cooperative, and their research questions are closely related. The analysis of highly cited literature and keywords confirmed the significant advantages of LDCT in lung cancer screening, which can help reduce the mortality of lung cancer patients and improve the prognosis. "Lung cancer" and "CT" have always been high-frequency keywords, while "image quality" and "low dose CT" have become new hot keywords, indicating that LDCT using deep learning techniques has become a hot topic in early lung cancer research. The study revealed that advancements in CT technology have driven in-depth research from application challenges to image processing, with the research trajectory evolving from technical improvements to health risk assessments and subsequently to AI-assisted diagnosis. Currently, the research focus has shifted toward integrating deep learning with LDCT technology to address complex diagnostic challenges. The study also presents global research trends and geographical distributions of LDCT technology, along with the influence of key research institutions and authors. The comprehensive analysis aims to promote the development and application of LDCT technology in pulmonary disease diagnosis and enhance diagnostic accuracy and patient management efficiency. The future will focus on LDCT reconstruction algorithms to balance image noise and radiation dose. AI-assisted multimodal imaging supports remote diagnosis and personalized health management by providing dynamic analysis, risk assessment, and follow-up recommendations to support early diagnosis.

Computed Tomography (CT) is widely acknowledged as the gold standard for diagnosing thoracic diseases. However, the accuracy of interpretation significantly depends on radiologists' expertise. Large Language Models (LLMs) have shown considerable promise in various medical applications, particularly in radiology. This study aims to assess the performance of leading LLMs in analyzing unstructured chest CT reports and to examine how different questioning methodologies and fine-tuning strategies influence their effectiveness in enhancing chest CT diagnosis. This retrospective analysis evaluated 13,489 chest CT reports encompassing 13 common thoracic conditions across pulmonary, cardiovascular, pleural, and upper abdominal systems. Five LLMs (Claude-3.5-Sonnet, GPT-4, GPT-3.5-Turbo, Gemini-Pro, Qwen-Max) were assessed using dual questioning methodologies: multiple-choice and open-ended. Radiologist-curated datasets underwent rigorous preprocessing, including RadLex terminology standardization, multi-step diagnostic validation, and exclusion of ambiguous cases. Model performance was quantified via Subjective Answer Accuracy Rate (SAAR), Reference Answer Accuracy Rate (RAAR), and Area Under the Receiver Operating Characteristic (ROC) Curve analysis. GPT-3.5-Turbo underwent fine-tuning (100 iterations with one training epoch) on 200 high-performing cases to enhance diagnostic precision for initially misclassified conditions. GPT-4 demonstrated superior performance with the highest RAAR of 75.1% in multiple-choice questioning, followed by Qwen-Max (66.0%) and Claude-3.5 (63.5%), significantly outperforming GPT-3.5-Turbo (41.8%) and Gemini-Pro (40.8%) across the entire patient cohort. Multiple-choice questioning consistently improved both RAAR and SAAR for all models compared to open-ended questioning, with RAAR consistently surpassing SAAR. Model performance demonstrated notable variations across different diseases and organ conditions. Notably, fine-tuning substantially enhanced the performance of GPT-3.5-Turbo, which initially exhibited suboptimal results in most scenarios. This study demonstrated that general-purpose LLMs can effectively interpret chest CT reports, with performance varying significantly across models depending on the questioning methodology and fine-tuning approaches employed. For surgical practice, these findings provided evidence-based guidance for selecting appropriate AI tools to enhance preoperative planning, particularly for thoracic procedures. The integration of optimized LLMs into surgical workflows may improve decision-making efficiency, risk stratification, and diagnostic speed, potentially contributing to better surgical outcomes through more accurate preoperative assessment.

<b>BACKGROUND.</b> The importance of including the thoracic aortic calcification (TAC), in addition to coronary artery calcification (CAC), in prognostic assessments has been difficult to determine, partly due to greater challenge in performing standardized TAC assessments. <b>OBJECTIVE.</b> The purpose of this study was to evaluate long-term prognostic implications of TAC assessed using artificial intelligence (AI)-based quantification on routine chest CT in a screening population. <b>METHODS.</b> This retrospective study included 7404 asymptomatic individuals (median age, 53.9 years; 5875 men, 1529 women) who underwent nongated noncontrast chest CT as part of a national general health screening program at one of two centers from January 2007 to December 2014. A commercial AI program quantified TAC and CAC using Agatston scores, which were stratified into categories. Radiologists manually quantified TAC and CAC in 2567 examinations. The role of AI-based TAC categories in predicting major adverse cardiovascular events (MACE) and all-cause mortality (ACM), independent of AI-based CAC categories as well as clinical and laboratory variables, was assessed by multivariable Cox proportional hazards models using data from both centers and concordance statistics from prognostic models developed and tested using center 1 and center 2 data, respectively. <b>RESULTS.</b> AI-based and manual quantification showed excellent agreement for TAC and CAC (concordance correlation coefficient: 0.967 and 0.895, respectively). The median observation periods were 7.5 years for MACE (383 events in 5342 individuals) and 11.0 years for ACM (292 events in 7404 individuals). When adjusted for AI-based CAC categories along with clinical and laboratory variables, the risk for MACE was not independently associated with any AI-based TAC category; risk of ACM was independently associated with AI-based TAC score of 1001-3000 (HR = 2.14, <i>p</i> = .02) but not with other AI-based TAC categories. When prognostic models were tested, the addition of AI-based TAC categories did not improve model fit relative to models containing clinical variables, laboratory variables, and AI-based CAC categories for MACE (concordance index [C-index] = 0.760-0.760, <i>p</i> = .81) or ACM (C-index = 0.823-0.830, <i>p</i> = .32). <b>CONCLUSION.</b> The addition of TAC to models containing CAC provided limited improvement in risk prediction in an asymptomatic screening population undergoing CT. <b>CLINICAL IMPACT.</b> AI-based quantification provides a standardized approach for better understanding the potential role of TAC as a predictive imaging biomarker.

Adjuvant chemotherapy provides a limited survival benefit (<5%) for patients with stage II colorectal cancer (CRC) and is suggested for high-risk patients. Given the heterogeneity of stage II CRC, we aimed to develop a clinically explainable artificial intelligence (AI)-powered analyser to identify radiological phenotypes that would benefit from chemotherapy. Multimodal data from patients with CRC across six cohorts were collected, including 405 patients from the Guangdong Provincial People's Hospital for model development and 153 patients from the Yunnan Provincial Cancer Centre for validation. RNA sequencing data were used to identify the differentially expressed genes in the two radiological clusters. Histopathological patterns were evaluated to bridge the gap between the imaging and genetic information. Finally, we investigated the discovered morphological patterns of mouse models to observe imaging features. The survival benefit of chemotherapy varied significantly among the AI-powered radiological clusters [interaction hazard ratio (iHR) = 5.35, (95% CI: 1.98, 14.41), adjusted P_interaction = 0.012]. Distinct biological pathways related to immune and stromal cell abundance were observed between the clusters. The observation only (OO)-preferable cluster exhibited higher necrosis, haemorrhage, and tortuous vessels, whereas the adjuvant chemotherapy (AC)-preferable cluster exhibited vessels with greater pericyte coverage, allowing for a more enriched infiltration of B, CD4⁺-T, and CD8⁺-T cells into the core tumoural areas. Further experiments confirmed that changes in vessel morphology led to alterations in predictive imaging features. The developed explainable AI-powered analyser effectively identified patients with stage II CRC with improved overall survival after receiving adjuvant chemotherapy, thereby contributing to the advancement of precision oncology. This work was funded by the National Science Fund of China (81925023, 82302299, and U22A2034), Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application (2022B1212010011), and High-level Hospital Construction Project (DFJHBF202105 and YKY-KF202204).

This study aimed to develop and validate machine learning models for preoperative identification of metastasis to station 4 mediastinal lymph nodes (MLNM) in non-small cell lung cancer (NSCLC) patients at pathological N0-N2 (pN0-pN2) stage, thereby enhancing the precision of clinical decision-making. We included a total of 356 NSCLC patients at pN0-pN2 stage, divided into training (n = 207), internal test (n = 90), and independent test (n = 59) sets. Station 4 mediastinal lymph nodes (LNs) regions of interest (ROIs) were semi-automatically segmented on venous-phase computed tomography (CT) images for radiomics feature extraction. Using least absolute shrinkage and selection operator (LASSO) regression to select features with non-zero coefficients. Four machine learning algorithms-decision tree (DT), logistic regression (LR), random forest (RF), and support vector machine (SVM)-were employed to construct radiomics models. Clinical predictors were identified through univariate and multivariate logistic regression, which were subsequently integrated with radiomics features to develop combined models. Models performance were evaluated using receiver operating characteristic (ROC) analysis, calibration curves, decision curve analysis (DCA), and DeLong's test. Out of 1721 radiomics features, eight radiomics features were selected using LASSO regression. The RF-based combined model exhibited the strongest discriminative power, with an area under the curve (AUC) of 0.934 for the training set and 0.889 for the internal test set. The calibration curve and DCA further indicated the superior performance of the combined model based on RF. The independent test set further verified the model's robustness. The combined model based on RF, integrating radiomics and clinical features, effectively and non-invasively identifies metastasis to the station 4 mediastinal LNs in NSCLC patients at pN0-pN2 stage. This model serves as an effective auxiliary tool for clinical decision-making and has the potential to optimize treatment strategies and improve prognostic assessment for pN0-pN2 patients. Not applicable.

Cone-beam CT (CBCT) scans that are affected by motion often require motion compensation to reduce artifacts or to reconstruct 4D (3D+time) representations of the patient. To do so, most existing strategies rely on some sort of gating strategy that sorts the acquired projections into motion bins. Subsequently, these bins can be reconstructed individually before further post-processing may be applied to improve image quality. While this concept is useful for periodic motion patterns, it fails in case of non-periodic motion as observed, for example, in irregularly breathing patients. To address this issue and to increase temporal resolution, we propose the deep single angle-based motion compensation (SAMoCo). To avoid gating, and therefore its downsides, the deep SAMoCo trains a U-net-like network to predict displacement vector fields (DVFs) representing the motion that occurred between any two given time points of the scan. To do so, 4D clinical CT scans are used to simulate 4D CBCT scans as well as the corresponding ground truth DVFs that map between the different motion states of the scan. The network is then trained to predict these DVFs as a function of the respective projection views and an initial 3D reconstruction. Once the network is trained, an arbitrary motion state corresponding to a certain projection view of the scan can be recovered by estimating DVFs from any other state or view and by considering them during reconstruction. Applied to 4D CBCT simulations of breathing patients, the deep SAMoCo provides high-quality reconstructions for periodic and non-periodic motion. Here, the deviations with respect to the ground truth are less than 27 HU on average, while respiratory motion, or the diaphragm position, can be resolved with an accuracy of about 0.75 mm. Similar results were obtained for real measurements where a high correlation with external motion monitoring signals could be observed, even in patients with highly irregular respiration. The ability to estimate DVFs as a function of two arbitrary projection views and an initial 3D reconstruction makes deep SAMoCo applicable to arbitrary motion patterns with single-view temporal resolution. Therefore, the deep SAMoCo is particularly useful for cases with unsteady breathing, compensation of residual motion during a breath-hold scan, or scans with fast gantry rotation times in which the data acquisition only covers a very limited number of breathing cycles. Furthermore, not requiring gating signals may simplify the clinical workflow and reduces the time needed for patient preparation.